Mednax Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Mednax (MD) PT Raised to $37 at BMO Capital
August 10, 2021 9:05 AM EDTBMO Capital analyst Matt Borsch raised the price target on Mednax (NYSE: MD) to $37.00 (from $35.00) while maintaining a Market Perform rating.
The analyst commented, "2Q was very solid with strength fueled by a resurgence of volumes. In fact, current volumes across MD's total... More
MEDNAX (MD) Tops Q2 EPS by 9c
August 6, 2021 6:06 AM EDTMEDNAX (NYSE: MD) reported Q2 EPS of $0.41, $0.09 better than the analyst estimate of $0.32. Revenue for the quarter came in at $473 million versus the consensus estimate of $448.94 million.
For earnings history and earnings-related data on MEDNAX (MD) click here.
... More